Added to YB: 2025-11-17
Pitch date: 2025-11-13
QNTM [neutral]
Quantum BioPharma Ltd.
+8.3%
current return
Author Info
Legal Special Situations is keeping you up to date with current legal issues in the commercial sphere, breaking down investment opportunities and market effects. Sign up for the newsletter.
Company Info
Quantum BioPharma Ltd., together with its subsidiaries, operates as a biopharmaceutical company. It operates through two segments, Biopharmaceutical Innovation and Strategic Investments.
Market Cap
CAD 32.8M
Pitch Price
CAD 10.00
Price Target
N/A
Dividend
N/A
EV/EBITDA
-1.78
P/E
-0.85
EV/Sales
N/A
Sector
Pharmaceuticals
Category
special_situation
This small cap bio-tech is taking on big banks for $700 million - Quantum BioPharma Ltd.
QNTM (legal special sit): Suing CIBC/RBC for alleged spoofing manipulation Jan 2020-Aug 2024, claiming $700M damages vs $35M market cap (20x ratio). CVRs pay 10-50% of net proceeds to shareholders. Contingency legal structure limits cash risk. Awaiting motion to dismiss ruling - key catalyst for case viability. High-risk binary outcome with compelling asymmetry if case survives.
Read full article (4 min)